scispace - formally typeset
A

Anastas Batalov

Researcher at Medical University Plovdiv

Publications -  60
Citations -  1005

Anastas Batalov is an academic researcher from Medical University Plovdiv. The author has contributed to research in topics: Medicine & Rheumatoid arthritis. The author has an hindex of 9, co-authored 46 publications receiving 588 citations.

Papers
More filters
Journal ArticleDOI

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, +212 more
- 29 Jul 2017 - 
TL;DR: Tofacitinib monotherapy was not shown to be non-inferior to either combination of adalimumab and methotrexate, and no new or unexpected safety issues were reported for either treatment in this study for up to 1 year.
Journal ArticleDOI

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

Dinesh Khanna, +89 more
TL;DR: Findings for the secondary endpoint of FVC% predicted indicate that tocilizumab might preserve lung function in people with early SSc-ILD and elevated acute-phase reactants.
Journal ArticleDOI

Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis

TL;DR: The findings suggest that YKL-40 might be implicated in the pathogenesis of the disease and could indicate the level of joint inflammation.